MedPath

Effect of Early Enteral Tube Feeding Nutrition With an Immune Enhancing Diet in Severe Burn Patients

Phase 4
Completed
Conditions
Infections on
Severe Burn Patients
Interventions
Dietary Supplement: Crucial
Dietary Supplement: Sondalis HP
Registration Number
NCT00561210
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

Compare clinical and biological effects of two enteral tube feeding nutrition formula (immune enhancing diet versus polymeric diet)in severe burn hospitalized patients .

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
57
Inclusion Criteria
  • Thermic burn from 20% to 80%
  • 15 < age < 70 years
  • written informed consent
Exclusion Criteria
  • diabetes mellitus
  • corticoid or immuno-suppressive therapy
  • HIV
  • evolutive cancers
  • pregnancy
  • abdominal lesion
  • hepatic or renal failure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ICrucialTotal enteral tube feeding
IISondalis HPTotal enteral tube feeding
Primary Outcome Measures
NameTimeMethod
Number of infections and number of multiple organ failure6 months
Secondary Outcome Measures
NameTimeMethod
digestive tolerance and healing6 months

Trial Locations

Locations (5)

CHU Pellegrin-Unites des brules

🇫🇷

Bordeaux, France

Hopital Hotel Dieu-Service des brules

🇫🇷

Nantes, France

Hôpital Edouard Herriot

🇫🇷

Lyon, France

Hôpital Saint Luc - Service des brûlés

🇫🇷

Lyon, France

Hopital Saint Antoine- Service des Brules

🇫🇷

Paris Cedex 12, France

© Copyright 2025. All Rights Reserved by MedPath